Pharm- Pyrimidine Antimetabolites Flashcards
5-Fluorouracil Distinctions
Active metabolites: FdUMP inhibs thymidylate synthase (inhibs dTMP synthesis) FdUTP & FUTP damage DNA & RNA
Capecitabine Distinctions
Oral pro-drug of 5FU
Gemcitabine Distinctions
Kinases convert gemcitabine to nucleotide analogs -> inhibs DNA synthesis
Cytarabine (Ara C) Distinctions
Kinases convert Ara-C to AraCTP -> inhibits DNA synthesis
5-FU Therapeutic Uses
Solid tumors: colorectal & other GI; breast, ovarian carcinomas. Topical: Basal cell carcinoma
Capecitabine Therapeutic Uses
Colorectal cancer; metastatic breast cancer (resistant to paclitaxel/anthracycline)
Gemcitabine Therapeutic Uses
Pancreatic Cancer
Cytarabine (Ara C) Therapeutic Uses
AML (with 6-thioguanine, daunorubicin)
5-FU Dose-Limiting Toxicity
Severe GI intolerance, mucositis, myelosuppression
Capecitabine Dose-Limiting Toxicity
Similar to 5FU + hand-foot syndrome
Gemcitabine Dose-Limiting Toxicity
Myelosuppression- Neutropenia
Cytarabine (Ara C)
Severe myelosuppression- Granulocytopenia
5FU
FdUMP inhibits thymidylate synthase -> thymineless death
what is 5FU almost always given with?
Folinic acid
clearance of 5FU
metabolic inactivation of 5FU by the liver
- DHFU is inactive metabolite
- inactivated by DPD in liver